Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.
复制标题
DOI:
10.1186/s40035-023-00393-7
复制
发表时间:
2024-01-04
影响因子:
12.6
通讯作者:
Moghe, Prabhas V.
中科院分区:
文献类型:
--
作者:
Gebril, Hoda M.;Aryasomayajula, Aravind;de Lima, Mariana Reis Nogueira;Uhrich, Kathryn E.;Moghe, Prabhas V.
关键词:
Alzheimer's disease (AD) is considered to have a multifactorial etiology. The hallmark of AD is progressive neurodegeneration, which is characterized by the deepening loss of memory and a high mortality rate in the elderly. The neurodegeneration in AD is believed to be exacerbated following the intercoupled cascades of extracellular amyloid beta (Aβ) plaques, uncontrolled microglial activation, and neuroinflammation. Current therapies for AD are mostly designed to target the symptoms, with limited ability to address the mechanistic triggers for the disease. In this study, we report a novel nanotechnology based on microglial scavenger receptor (SR)-targeting amphiphilic nanoparticles (NPs) for the convergent alleviation of fibril Aβ (fAβ) burden, microglial modulation, and neuroprotection. We designed a nanotechnology approach to regulate the SR-mediated intracellular fAβ trafficking within microglia. We synthesized SR-targeting sugar-based amphiphilic macromolecules (AM) and used them as a bioactive shell to fabricate serum-stable AM–NPs via flash nanoprecipitation. Using electron microscopy, in vitro approaches, ELISA, and confocal microscopy, we investigated the effect of AM–NPs on Aβ fibrilization, fAβ-mediated microglial inflammation, and neurotoxicity in BV2 microglia and SH-SY5Y neuroblastoma cell lines. AM–NPs interrupted Aβ fibrilization, attenuated fAβ microglial internalization via targeting the fAβ-specific SRs, arrested the fAβ-mediated microglial activation and pro-inflammatory response, and accelerated lysosomal degradation of intracellular fAβ. Moreover, AM–NPs counteracted the microglial-mediated neurotoxicity after exposure to fAβ. The AM–NP nanotechnology presents a multifactorial strategy to target pathological Aβ aggregation and arrest the fAβ-mediated pathological progression in microglia and neurons. The online version contains supplementary material available at 10.1186/s40035-023-00393-7.
登录
查看更多内容
影响因子:
15.3
作者:
El Khoury, JB;Moore, KJ;Means, TK;Leung, J;Terada, K;Toft, M;Freeman, MW;Luster, AD
通讯作者:
Luster, AD
影响因子:
7.8
作者:
Caccamo A;Magrì A;Medina DX;Wisely EV;López-Aranda MF;Silva AJ;Oddo S
通讯作者:
Oddo S
影响因子:
168.9
作者:
Cagnin, A;Brooks, DJ;Banati, RB
通讯作者:
Banati, RB
影响因子:
5.3
作者:
Combs, CK;Johnson, DE;Landreth, GE
通讯作者:
Landreth, GE
影响因子:
6
作者:
Coraci, IS;Husemann, J;El Khoury, JB
通讯作者:
El Khoury, JB